...
首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions.
【24h】

Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions.

机译:纯碳酸氢盐腹膜透析解决方案的长期临床经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: The aim of this prospective study was to collect long-term experience in incident peritoneal dialysis (PD) patients treated with pure bicarbonate-buffered PD fluids. METHODS: The metabolic parameters acidosis, acid-base status, adequacy, fluid balance, nutritional markers, calcium, phosphorus, parathyroid hormone (PTH), and general laboratory work and medication were compared between incident PD patients in two groups: one treated with a 34 mmol/L bicarbonate-buffered PD fluid (BIC), the other with a 35 mmol/L lactate-buffered PD fluid (LAC). The observation period included 5 visits from 1 month (visit 1) until 12 months (visit 5) after the start of dialysis treatment. For the descriptive analysis, means and standard deviations were calculated. Student's t-test and linear mixed models were used to compare the two treatment groups. RESULTS: 36 patients were followed for 12 months, 18 in the BIC group and 18 in the LAC group. Statistically significant differences between the groups (at the end of study) were found. In BIC group, venous plasma bicarbonate was 27.4 +/- 2.3 mmol/L, base excess 0.8 +/- 2.2 mmol/L, and pH 7.31 +/- 0.05; in LAC group, venous bicarbonate was 25.9 +/- 2.4 mmol/L, base excess -0.6 +/- 2.1 mmol/L, and pH 7.30 +/- 0.04. No patient from the BIC group needed oral bicarbonate, in contrast to 4 patients in the LAC group. Whereas peritoneal urea and creatinine clearances did not differ between the groups, there was better renal solute clearance in the BIC group, accompanied by better-preserved diuresis at 12 months (1333 +/- 935 mL with BIC vs 839 +/- 556 mL with LAC). The reverse was true for ultrafiltration. CONCLUSIONS: Pure bicarbonate-buffered PD solutions were superior in correcting metabolic acidosis and they allowed omission of oral bicarbonate. The minor ultrafiltration with bicarbonate-buffered PD solutions was counterbalanced by better-preserved residual renal function with these solutions.
机译:目的:这项前瞻性研究的目的是收集接受纯碳酸氢盐缓冲的PD液治疗的腹膜透析(PD)患者的长期经验。方法:比较两组PD患者之间的代谢参数酸中毒,酸碱状态,充足性,体液平衡,营养指标,钙,磷,甲状旁腺激素(PTH)以及一般实验室工作和药物治疗:一组34 mmol / L碳酸氢盐缓冲的PD液(BIC),另一种含35 mmol / L乳酸缓冲的PD液(LAC)。观察期包括从透析治疗开始后的1个月(第1次访问)到12个月(第5次访问)之间的5次访问。为了进行描述性分析,计算了均值和标准差。使用学生t检验和线性混合模型比较两个治疗组。结果:36例患者接受了12个月的随访,BIC组18例,LAC组18例。发现两组之间(研究结束时)有统计学差异。 BIC组静脉血浆碳酸氢盐浓度为27.4 +/- 2.3 mmol / L,碱过量0.8 +/- 2.2 mmol / L,pH值为7.31 +/- 0.05。 LAC组中的碳酸氢盐静脉血为25.9 +/- 2.4 mmol / L,碱过量-0.6 +/- 2.1 mmol / L,pH为7.30 +/- 0.04。 BIC组中没有患者需要口服碳酸氢盐,而LAC组中有4名患者。尽管两组之间的腹膜尿素和肌酐清除率没有差异,但BIC组的肾溶质清除率更高,并伴有12个月的利尿剂保存更好(BIC为1333 +/- 935 mL,而BIC为839 +/- 556 mL。 LAC)。反之适用于超滤。结论:纯碳酸氢盐缓冲的PD溶液在纠正代谢性酸中毒方面具有优势,并且可以省略口服碳酸氢盐。用碳酸氢盐缓冲的PD溶液进行的轻微超滤被这些溶液保留得更好的残余肾功能所抵消。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号